Analystreport

Acorda Therapeutics (NASDAQ: ACOR) was given a new $31.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors